Clinical Trials Directory

Trials / Completed

CompletedNCT04202029

Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement

Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring by Non- Anesthesiologist During Percutaneous Endoscopic Gastrostomy (PEG), a Prospective, Randomized-controlled Clinical Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
173 (actual)
Sponsor
Georg Dultz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study is a randomized, prospective, single-blinded study. A total of 172 patients presenting for percoutaneous endoscopic gastrostomy (PEG) under sedation will be included according to the statistical sample size calculation. Patients will be randomized to either group 1- standard monitoring (pulseoxymetry and non-invasive blood preassure monitoring) or group 2- standard monitoring and thoracic impedance measurement during Propofol-based sedation for PEG. Episodes of Hypoxia are documented and compared in both groups. Statistical analysis will be done in cooperation with the statistical biomedical institute oft he university hospital in Frankfurt.

Conditions

Interventions

TypeNameDescription
DEVICEthoracic impedance monitoringThoracic impedance measurement identifies the respiratory frequence using the changes of impedance during inspiration and expiration via an ECG.
DEVICEpulseoxymetryPulseoxymetry is meassuring the heart rate and the oxygen saturation in the arterial blood
DEVICEnon-invasive blood preassure monitoringNon-invasive blood preassure is a method using a blood preassure cuff to identify the blood preassure.

Timeline

Start date
2019-11-04
Primary completion
2021-08-24
Completion
2021-08-24
First posted
2019-12-17
Last updated
2023-07-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04202029. Inclusion in this directory is not an endorsement.